What makes placebo-controlled trials unethical?

Howard Brody

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

This chapter examines the debate over the ethics of placebo-controlled trials. The ethical reasoning underlying a prohibition of placebo controls in randomized controlled trials when proven effective treatments exist has been presented most clearly and persuasively by the late Benjamin Freedman and his colleagues, who advanced two arguments in support of this ethical stance. First, the use of placebo-controlled trials in the face of proven effective treatments violates the physician's therapeutic obligation to offer optimal medical care to patients. Second, testing new treatments against placebo when proven effective treatments exist lacks scientific and clinical merit. These two arguments are linked by the principle of clinical equipoise, first formulated by Freedman. This chapter rejects both arguments, claiming that they fail to withstand critical scrutiny in light of the ethically fundamental distinction between clinical research and clinical care, as well as appropriate ethical standards of risk-benefit assessment for clinical research. It argues that the principle of clinical equipoise confuses the ethics of clinical research with the ethics of clinical medicine and that its ethical guidance on the use of placebo-controlled trials is erroneous.

Original languageEnglish (US)
Title of host publicationThe Ethical Challenges of Human Research: Selected Essays
PublisherOxford University Press
ISBN (Print)9780190267681, 9780199896202
DOIs
StatePublished - Nov 15 2012
Externally publishedYes

Fingerprint

Placebo
Controlled
Clinical Research
Fundamental
Medicine
Physicians
Medical Care
Merit
Guidance
Obligation
Ethical Standards
Testing
Scrutiny
Prohibition
Randomized Controlled Trial
Therapeutics
Stance

Keywords

  • Benjamin freedman
  • Clinical care
  • Clinical equipoise
  • Clinical medicine
  • Clinical research
  • Placebo
  • Placebo-controlled trials
  • Randomized controlled trials
  • Research ethics
  • Risk-benefit assessment

ASJC Scopus subject areas

  • Arts and Humanities(all)

Cite this

Brody, H. (2012). What makes placebo-controlled trials unethical? In The Ethical Challenges of Human Research: Selected Essays Oxford University Press. https://doi.org/10.1093/acprof:osobl/9780199896202.003.0007

What makes placebo-controlled trials unethical? / Brody, Howard.

The Ethical Challenges of Human Research: Selected Essays. Oxford University Press, 2012.

Research output: Chapter in Book/Report/Conference proceedingChapter

Brody, H 2012, What makes placebo-controlled trials unethical? in The Ethical Challenges of Human Research: Selected Essays. Oxford University Press. https://doi.org/10.1093/acprof:osobl/9780199896202.003.0007
Brody H. What makes placebo-controlled trials unethical? In The Ethical Challenges of Human Research: Selected Essays. Oxford University Press. 2012 https://doi.org/10.1093/acprof:osobl/9780199896202.003.0007
Brody, Howard. / What makes placebo-controlled trials unethical?. The Ethical Challenges of Human Research: Selected Essays. Oxford University Press, 2012.
@inbook{9b6b07a11eb54103aece4d0305d3dd5d,
title = "What makes placebo-controlled trials unethical?",
abstract = "This chapter examines the debate over the ethics of placebo-controlled trials. The ethical reasoning underlying a prohibition of placebo controls in randomized controlled trials when proven effective treatments exist has been presented most clearly and persuasively by the late Benjamin Freedman and his colleagues, who advanced two arguments in support of this ethical stance. First, the use of placebo-controlled trials in the face of proven effective treatments violates the physician's therapeutic obligation to offer optimal medical care to patients. Second, testing new treatments against placebo when proven effective treatments exist lacks scientific and clinical merit. These two arguments are linked by the principle of clinical equipoise, first formulated by Freedman. This chapter rejects both arguments, claiming that they fail to withstand critical scrutiny in light of the ethically fundamental distinction between clinical research and clinical care, as well as appropriate ethical standards of risk-benefit assessment for clinical research. It argues that the principle of clinical equipoise confuses the ethics of clinical research with the ethics of clinical medicine and that its ethical guidance on the use of placebo-controlled trials is erroneous.",
keywords = "Benjamin freedman, Clinical care, Clinical equipoise, Clinical medicine, Clinical research, Placebo, Placebo-controlled trials, Randomized controlled trials, Research ethics, Risk-benefit assessment",
author = "Howard Brody",
year = "2012",
month = "11",
day = "15",
doi = "10.1093/acprof:osobl/9780199896202.003.0007",
language = "English (US)",
isbn = "9780190267681",
booktitle = "The Ethical Challenges of Human Research: Selected Essays",
publisher = "Oxford University Press",

}

TY - CHAP

T1 - What makes placebo-controlled trials unethical?

AU - Brody, Howard

PY - 2012/11/15

Y1 - 2012/11/15

N2 - This chapter examines the debate over the ethics of placebo-controlled trials. The ethical reasoning underlying a prohibition of placebo controls in randomized controlled trials when proven effective treatments exist has been presented most clearly and persuasively by the late Benjamin Freedman and his colleagues, who advanced two arguments in support of this ethical stance. First, the use of placebo-controlled trials in the face of proven effective treatments violates the physician's therapeutic obligation to offer optimal medical care to patients. Second, testing new treatments against placebo when proven effective treatments exist lacks scientific and clinical merit. These two arguments are linked by the principle of clinical equipoise, first formulated by Freedman. This chapter rejects both arguments, claiming that they fail to withstand critical scrutiny in light of the ethically fundamental distinction between clinical research and clinical care, as well as appropriate ethical standards of risk-benefit assessment for clinical research. It argues that the principle of clinical equipoise confuses the ethics of clinical research with the ethics of clinical medicine and that its ethical guidance on the use of placebo-controlled trials is erroneous.

AB - This chapter examines the debate over the ethics of placebo-controlled trials. The ethical reasoning underlying a prohibition of placebo controls in randomized controlled trials when proven effective treatments exist has been presented most clearly and persuasively by the late Benjamin Freedman and his colleagues, who advanced two arguments in support of this ethical stance. First, the use of placebo-controlled trials in the face of proven effective treatments violates the physician's therapeutic obligation to offer optimal medical care to patients. Second, testing new treatments against placebo when proven effective treatments exist lacks scientific and clinical merit. These two arguments are linked by the principle of clinical equipoise, first formulated by Freedman. This chapter rejects both arguments, claiming that they fail to withstand critical scrutiny in light of the ethically fundamental distinction between clinical research and clinical care, as well as appropriate ethical standards of risk-benefit assessment for clinical research. It argues that the principle of clinical equipoise confuses the ethics of clinical research with the ethics of clinical medicine and that its ethical guidance on the use of placebo-controlled trials is erroneous.

KW - Benjamin freedman

KW - Clinical care

KW - Clinical equipoise

KW - Clinical medicine

KW - Clinical research

KW - Placebo

KW - Placebo-controlled trials

KW - Randomized controlled trials

KW - Research ethics

KW - Risk-benefit assessment

UR - http://www.scopus.com/inward/record.url?scp=84938634856&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84938634856&partnerID=8YFLogxK

U2 - 10.1093/acprof:osobl/9780199896202.003.0007

DO - 10.1093/acprof:osobl/9780199896202.003.0007

M3 - Chapter

AN - SCOPUS:84938634856

SN - 9780190267681

SN - 9780199896202

BT - The Ethical Challenges of Human Research: Selected Essays

PB - Oxford University Press

ER -